These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37337229)

  • 1. Low-carbohydrate diet in the treatment of type 2 diabetes mellitus (LoCaT): study protocol for a multicenter, randomized controlled trial.
    Xia X; Xu M; Gu Y; Li Y; Li L; Yin J
    Trials; 2023 Jun; 24(1):411. PubMed ID: 37337229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial.
    Yang X; He Z; Yuan L; Huang W; Li D; Xiang P; Chen Y; Chen G; Liu C
    BMC Endocr Disord; 2023 Oct; 23(1):215. PubMed ID: 37814256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Low-Carbohydrate Diet on Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Wang LL; Wang Q; Hong Y; Ojo O; Jiang Q; Hou YY; Huang YH; Wang XH
    Nutrients; 2018 May; 10(6):. PubMed ID: 29882884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-carbohydrate dietary pattern on glycemic outcomes trial (ADEPT) among individuals with elevated hemoglobin A1c: study protocol for a randomized controlled trial.
    Dorans KS; Bazzano LA; Qi L; He H; Appel LJ; Samet JM; Chen J; Mills KT; Nguyen BT; O'Brien MJ; Uwaifo GI; He J
    Trials; 2021 Feb; 22(1):108. PubMed ID: 33522954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low carbohydrate diets on weight and glycemic control among type 2 diabetes individuals: a systemic review of RCT greater than 12 weeks.
    Castañeda-González LM; Bacardí Gascón M; Jiménez Cruz A
    Nutr Hosp; 2011; 26(6):1270-6. PubMed ID: 22411372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial.
    Griauzde DH; O'Brien A; Yancy WS; Richardson CR; Krinock J; DeJonckheere M; Isaman DJM; Vanias K; Shopinski S; Saslow LR
    Trials; 2022 Sep; 23(1):827. PubMed ID: 36176003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Low-Carbohydrate Diet Realizes Medication Withdrawal: A Possible Opportunity for Effective Glycemic Control.
    Han Y; Cheng B; Guo Y; Wang Q; Yang N; Lin P
    Front Endocrinol (Lausanne); 2021; 12():779636. PubMed ID: 34970224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: the Pharm-TCR randomized controlled trial protocol.
    Durrer C; McKelvey S; Singer J; Batterham AM; Johnson JD; Wortman J; Little JP
    Trials; 2019 Dec; 20(1):781. PubMed ID: 31881991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of 130 g/day low-carbohydrate diet in type 2 diabetes with poor glycemic control.
    Sato J; Kanazawa A; Makita S; Hatae C; Komiya K; Shimizu T; Ikeda F; Tamura Y; Ogihara T; Mita T; Goto H; Uchida T; Miyatsuka T; Takeno K; Shimada S; Ohmura C; Watanabe T; Kobayashi K; Miura Y; Iwaoka M; Hirashima N; Fujitani Y; Watada H
    Clin Nutr; 2017 Aug; 36(4):992-1000. PubMed ID: 27472929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of canagliflozin on body weight and body composition in patients with type 2 diabetes over 104 weeks.
    Blonde L; Stenlöf K; Fung A; Xie J; Canovatchel W; Meininger G
    Postgrad Med; 2016 May; 128(4):371-80. PubMed ID: 27002421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial.
    Esposito K; Maiorino MI; Ciotola M; Di Palo C; Scognamiglio P; Gicchino M; Petrizzo M; Saccomanno F; Beneduce F; Ceriello A; Giugliano D
    Ann Intern Med; 2009 Sep; 151(5):306-14. PubMed ID: 19721018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Almond-Based Low Carbohydrate Diet Improves Depression and Glycometabolism in Patients with Type 2 Diabetes through Modulating Gut Microbiota and GLP-1: A Randomized Controlled Trial.
    Ren M; Zhang H; Qi J; Hu A; Jiang Q; Hou Y; Feng Q; Ojo O; Wang X
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33022991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.
    Seko Y; Sumida Y; Sasaki K; Itoh Y; Iijima H; Hashimoto T; Ishii S; Inagaki N
    J Gastroenterol; 2018 Jan; 53(1):140-151. PubMed ID: 28669071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
    Hansen CD; Gram-Kampmann EM; Hansen JK; Hugger MB; Madsen BS; Jensen JM; Olesen S; Torp N; Rasmussen DN; Kjærgaard M; Johansen S; Lindvig KP; Andersen P; Thorhauge KH; Brønd JC; Hermann P; Beck-Nielsen H; Detlefsen S; Hansen T; Højlund K; Thiele MS; Israelsen M; Krag A
    Ann Intern Med; 2023 Jan; 176(1):10-21. PubMed ID: 36508737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a randomized controlled trial comparing a very low-carbohydrate diet or moderate-carbohydrate plate-method diet for type 2 diabetes: the LEGEND (Lifestyle Education about Nutrition for Diabetes) trial.
    Saslow LR; Eslamian A; Moran P; Hartogensis W; Mason AE; Kim S; Bauer DC; Griauzde DH; Goldman V; Liu V; Stephens P; Raymond K; Yeung G; Leung C; Hecht FM
    Trials; 2023 Jul; 24(1):463. PubMed ID: 37475033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low-carbohydrate diet.
    Nishimura R; Omiya H; Sugio K; Ubukata M; Sakai S; Samukawa Y
    Diabetes Obes Metab; 2016 Jul; 18(7):702-6. PubMed ID: 26639943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: An open-label randomized controlled trial.
    Gram-Kampmann EM; Hansen CD; Hugger MB; Jensen JM; Brønd JC; Hermann AP; Krag A; Olsen MH; Beck-Nielsen H; Højlund K
    Diabetes Obes Metab; 2022 Apr; 24(4):693-703. PubMed ID: 34984805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes.
    Mayer SB; Jeffreys AS; Olsen MK; McDuffie JR; Feinglos MN; Yancy WS
    Diabetes Obes Metab; 2014 Jan; 16(1):90-3. PubMed ID: 23911112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials.
    Blonde L; Woo V; Mathieu C; Yee J; Vijapurkar U; Canovatchel W; Meininger G
    Curr Med Res Opin; 2015 Nov; 31(11):1993-2000. PubMed ID: 26373629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial.
    Liu Z; Zhang K; Zhang J; Wang F; Zhou Y; Wang L; Wang M; Zhang Y; Zhou S
    Trials; 2023 Apr; 24(1):283. PubMed ID: 37076915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.